Related Experiment Videos
[Hormone therapies in pregnancy].
G A Tommaselli1, M Pellicano, M Guida
1Dipartimento di Ginecologia, Ostetricia e Fisiopatologia della Riproduzione Umana, Università degli Studi di Napoli, Federico II, Napoli, Italy.
Minerva Ginecologica
|May 29, 2002
Summary
Maternal endocrine disorders pose risks to both mother and fetus during pregnancy. This review examines these conditions, their effects, and safe treatment options for expectant mothers.
Area of Science:
- Endocrinology
- Maternal-Fetal Medicine
- Pharmacology
Context:
- Pregnancy can significantly alter the course of maternal endocrine disorders.
- Endocrine conditions may arise during pregnancy, impacting maternal and fetal health.
- Therapeutic interventions for endocrine disorders require careful consideration during gestation.
Purpose:
- To review the incidence and evolution of major maternal endocrine disorders during pregnancy.
- To discuss the effects of these disorders on maternal and fetal well-being.
- To explore current and emerging treatment strategies for endocrine conditions in pregnant patients.
Summary:
- Maternal endocrine disorders present significant risks, affecting both the pregnant individual and the developing fetus.
- Assessing the safety of endocrine therapies during pregnancy is crucial, evaluating fetal effects, placental transfer, and teratogenic potential.
- This review syntheses information on endocrine disorder prevalence, pregnancy-related changes, maternal-fetal impacts, and updated treatment guidelines.
Impact:
- Provides critical information for clinicians managing endocrine disorders in pregnant patients.
- Highlights the importance of risk-benefit assessments for maternal pharmacotherapy.
- Contributes to improved understanding and management of endocrine health during pregnancy.